Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
TIL Instil Bio
1.330
+0.030+2.31%
Post Mkt Price
1.3300.0000.00%
YOY
Do not show
Hide blank lines
(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31
Total revenue
0 0 0 0
Operating revenue
-- 0 -- 0 -- 0 -- 0
Cost of revenue
Gross profit
Operating expense
31.67% 56.65M 65.98% 58.72M 131.96% 54.29M 360.48% 155.56M
Selling and administrative expenses
21.70% 16.99M 21.34% 17.22M 68.30% 15.11M 235.88% 48.31M
-General and administrative expense
21.70% 16.99M 21.34% 17.22M 68.30% 15.11M 235.88% 48.31M
Research and development costs
36.46% 39.66M 95.88% 41.5M 171.59% 39.17M 452.87% 107.25M
Operating profit
-31.67% -56.65M -65.98% -58.72M -131.96% -54.29M -362.37% -155.56M
Net non-operating interest income expense
173.40% 469K 274.16% 155K
Non-operating interest income
-- 1.28M -- 486K -- -- -- --
Non-operating interest expense
-- 807K -- 331K -- -- -- --
Other net income (expense)
-415K -1.03M -319K 70.22% -1.2M
Other non- operating income (expenses)
-- -415K -- -1.03M -- -319K 74.33% -1.2M
Income before tax
-29.62% -56.6M -68.03% -59.6M -134.03% -54.61M -317.05% -156.76M
Income tax
43.62% -371K -283.02% -609K -139.22% -488K -74.17% 39K
Net income
-30.74% -56.22M -67.06% -58.99M -133.99% -54.12M -315.48% -156.79M
Net income continuous Operations
-30.74% -56.22M -67.06% -58.99M -133.99% -54.12M -315.48% -156.79M
Minority interest income
Net income attributable to the parent company
-30.74% -56.22M -67.06% -58.99M -133.99% -54.12M -315.48% -156.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-30.74% -56.22M -67.06% -58.99M -133.99% -54.12M -315.48% -156.79M
Basic earnings per share
-30.30% -0.43 -70.37% -0.46 36.36% -0.42 -142.62% -1.48
Diluted earnings per share
-30.30% -0.43 -70.37% -0.46 36.36% -0.42 -142.62% -1.48
Dividend per share
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
------Unqualified Opinion

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Instil Bio, Inc. is a clinical-stage biopharmaceutical company engaged in developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte therapies for the treatment of patients with cancer. The company was founded in August 2018 and is headquartered in Dallas, TX.
CEO: Mr. Bronson Crouch
Market: NASDAQ
Listing Date: 03/19/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist